Skip to main content

Natus Medical Awarded Key New Government Contract

Paves the Way for Purchase of Natus Medical Equipment Through United States Government Healthcare System Electronic Catalog

PLEASANTON, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce the award of a 5-year contract to include Natus Patient Monitoring and Capital Equipment (PMCE) in the electronic catalog (ECAT). The PMCE contract is pre-established and pre-vetted by the Defense Logistics Agency (DLA) as a source for medical equipment and acts as a preferred purchasing source for United States government healthcare systems. ECAT, as an on-line ordering, distribution and payment solution facilitates over $1B in purchase activity annually.

The PMCE contract and ECAT integration will now provide easier access for the Department of Defense (DoD) and Veterans Affairs (VA) health systems to purchase many products across the Natus portfolio, including neurodiagnostic, audiology and newborn care equipment and supplies. The initial 5-year contract term also includes an additional 5-year extension option.

“We are excited to achieve this important milestone,” says Jonathan Kennedy, Natus CEO. “This agreement and Natus inclusion in the electronic catalog solution will dramatically improve the transaction process, making it easier for us to partner with government healthcare systems and provide our innovative solutions to the United States veteran and active-duty military patients in need.”  

About Natus Medical Incorporated

Natus Medical Incorporated improves patient outcomes using the most comprehensive product solutions, depth of training and continuing customer care when diagnosing and treating central nervous and sensory system disorders for patients of all ages.

Additional information about Natus Medical Incorporated can be found at https://natus.com.

Contacts:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com                

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.